Skip to content
PubMed This is a summary of 75 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 75 referenced papers

Top Authors

Jyotirmay Biswas
Sankara Nethralaya
C. Stephen Foster
Harvard University
Rupesh Agrawal
Singapore National Eye Center
Carlos Pavésio
Moorfields Eye Hospital NHS Foundation Trust
Aniki Rothová
Erasmus MC
Peter McCluskey
The George Institute for Global Health

Top Institutions

Ranked by publications Top 10 institutions
02

Harvard University

Cambridge, United States

17 papers
03

Moorfields Eye Hospital NHS Foundation Trust

London, United Kingdom

10 papers
09

The George Institute for Global Health

Sydney, Australia

8 papers
Contributors Peter McCluskey

References

References (75)
  1. 1

    Optical coherence tomography in the diagnosis of scleritis and episcleritis.

    Shoughy SS, Jaroudi MO, Kozak I, Tabbara KF

    American journal of ophthalmology 2015; (159(6)):1045-1049.e1.

    PMID: 25771347
  2. 2

    Nodular syphilitic scleritis masquerading as an ocular tumor.

    Shaikh SI, Biswas J, Rishi P

    Journal of ophthalmic inflammation and infection 2015; (5()):8 doi:10.1186/s12348-015-0040-5.

    PMID: 25861399
  3. 3

    Posterior Scleritis: Analysis of Epidemiology, Clinical Factors, and Risk of Recurrence in a Cohort of 114 Patients.

    Lavric A, Gonzalez-Lopez JJ, Majumder PD, et al.

    Ocular immunology and inflammation 2016; (24(1)):6-15 doi:10.3109/09273948.2015.1005240.

    PMID: 26134101
  4. 4

    [Diagnosis and treatment approach for necrotizing scleritis (NS): A clinical case].

    Hernández-Camarena JC, Rodríguez-García A, Valdez-García J

    Gaceta medica de Mexico 2015; (151(4)):525-8.

    PMID: 26290030
  5. 5

    NODULAR POSTERIOR SCLERITIS: Clinico-Sonographic Characteristics and Proposed Diagnostic Criteria.

    Agrawal R, Lavric A, Restori M, et al.

    Retina (Philadelphia, Pa.) 2016; (36(2)):392-401 doi:10.1097/IAE.0000000000000699.

    PMID: 26296144
  6. 6

    Scleritis in patients with granulomatosis with polyangiitis (Wegener).

    Cocho L, Gonzalez-Gonzalez LA, Molina-Prat N, et al.

    The British journal of ophthalmology 2016; (100(8)):1062-5 doi:10.1136/bjophthalmol-2015-307460.

    PMID: 26567022
  7. 7

    Anterior segment spectral domain optical coherence tomography imaging of patients with anterior scleritis.

    Levison AL, Lowder CY, Baynes KM, et al.

    International ophthalmology 2016; (36(4)):499-508 doi:10.1007/s10792-015-0153-8.

    PMID: 26597942
  8. 8

    Rituximab in the Treatment of Refractory Noninfectious Scleritis.

    Cao JH, Oray M, Cocho L, Foster CS

    American journal of ophthalmology 2016; (164()):22-8.

    PMID: 26766304
  9. 9

    Scleritis associated with relapsing polychondritis.

    Sainz-de-la-Maza M, Molina N, Gonzalez-Gonzalez LA, et al.

    The British journal of ophthalmology 2016; (100(9)):1290-4 doi:10.1136/bjophthalmol-2015-306902.

    PMID: 26888976
  10. 10

    Treatment and management of scleral disorders.

    Daniel Diaz J, Sobol EK, Gritz DC

    Survey of ophthalmology 2016; (61(6)):702-717 doi:10.1016/j.survophthal.2016.06.002.

    PMID: 27318032
  11. 11

    Morphological features in anterior scleral inflammation using swept-source optical coherence tomography with multiple B-scan averaging.

    Kuroda Y, Uji A, Morooka S, et al.

    The British journal of ophthalmology 2017; (101(4)):411-417 doi:10.1136/bjophthalmol-2016-308561.

    PMID: 27388252
  12. 12

    [Diagnosis and treatment of episcleritis and scleritis].

    Tappeiner C, Walscheid K, Heiligenhaus A

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2016; (113(9)):797-810 doi:10.1007/s00347-016-0344-3.

    PMID: 27550224
  13. 13

    Clinical Profile of Patients with Necrotizing Scleritis in a Tertiary Eye Care Center in Southern India.

    Dutta Majumder P, Ghose A, Chidambaram M, et al.

    Ocular immunology and inflammation 2018; (26(3)):412-416 doi:10.1080/09273948.2016.1223857.

    PMID: 27762661
  14. 14

    Association of Low Vitamin D Levels With Noninfectious Anterior Uveitis.

    Grotting LA, Davoudi S, Palenzuela D, et al.

    JAMA ophthalmology 2017; (135(2)):150-153 doi:10.1001/jamaophthalmol.2016.4888.

    PMID: 28006052
  15. 15

    Occult Fungal Scleritis.

    Jeang LJ, Davis A, Madow B, et al.

    Ocular oncology and pathology 2017; (3(1)):41-44 doi:10.1159/000449103.

    PMID: 28275602
  16. 16

    Ocular Pharmacology for Scleritis: Review of Treatment and a Practical Perspective.

    Stem MS, Todorich B, Faia LJ

    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2017; (33(4)):240-246 doi:10.1089/jop.2016.0127.

    PMID: 28355124
  17. 17

    Experience of scleritis and episcleritis at a tertiary center in Southern Taiwan.

    Chen YW, Poon YC, Yu HJ, et al.

    Taiwan journal of ophthalmology 2015; (5(1)):19-22 doi:10.1016/j.tjo.2014.10.004.

    PMID: 29018659
  18. 18

    [Scleritis and systemic diseases: What should know the internist?]

    Bielefeld P, Saadoun D, Héron E, et al.

    La Revue de medecine interne 2018; (39(9)):711-720 doi:10.1016/j.revmed.2018.02.001.

    PMID: 29496270
  19. 19

    Scleral Patch Graft With a Suture Reinforcement Technique in Surgical Management of Necrotizing Scleritis With Ectasia.

    Wen JC, Lam J, Banitt MR

    Cornea 2018; (37(7)):933-935 doi:10.1097/ICO.0000000000001598.

    PMID: 29664747
  20. 20

    Clinical characteristics and ocular complications of patients with scleritis in Japanese.

    Tanaka R, Kaburaki T, Ohtomo K, et al.

    Japanese journal of ophthalmology 2018; (62(4)):517-524 doi:10.1007/s10384-018-0600-y.

    PMID: 29796754
  21. 21

    Clinical profile of patients with posterior scleritis: A report from Eastern India.

    Kumar A, Ghose A, Biswas J, Majumder PD

    Indian journal of ophthalmology 2018; (66(8)):1109-1112 doi:10.4103/ijo.IJO_121_18.

    PMID: 30038152
  22. 22

    Methotrexate for the treatment of noninfectious scleritis.

    Sands DS, Chan SCY, Gottlieb CC

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2018; (53(4)):349-353 doi:10.1016/j.jcjo.2017.11.009.

    PMID: 30119788
  23. 23

    Presumed Tuberculous Sclerokeratitis Presenting with Hypopyon.

    Dutta Majumder P

    Ocular immunology and inflammation 2019; (27(7)):1121-1123 doi:10.1080/09273948.2018.1511812.

    PMID: 30148654
  24. 24

    Pattern of Scleritis in an Egyptian Cohort.

    Abd El Latif E, Seleet MM, El Hennawi H, et al.

    Ocular immunology and inflammation 2019; (27(6)):890-896 doi:10.1080/09273948.2018.1544372.

    PMID: 30412434
  25. 25

    The clinical features of posterior scleritis with serous retinal detachment: a retrospective clinical analysis.

    Dong ZZ, Gan YF, Zhang YN, et al.

    International journal of ophthalmology 2019; (12(7)):1151-1157 doi:10.18240/ijo.2019.07.16.

    PMID: 31341807
  26. 26

    Ocular complications and mortality in peripheral ulcerative keratitis and necrotising scleritis: The role of systemic immunosuppression.

    Ogra S, Sims JL, McGhee CNJ, Niederer RL

    Clinical & experimental ophthalmology 2020; (48(4)):434-441 doi:10.1111/ceo.13709.

    PMID: 31872475
  27. 27

    Noninfectious Autoimmune Scleritis: Recognition, Systemic Associations, and Therapy.

    Nevares A, Raut R, Libman B, Hajj-Ali R

    Current rheumatology reports 2020; (22(4)):11 doi:10.1007/s11926-020-0885-y.

    PMID: 32219644
  28. 28

    Epidemiology of episcleritis and scleritis in urban Australia.

    Thong LP, Rogers SL, Hart CT, et al.

    Clinical & experimental ophthalmology 2020; (48(6)):757-766 doi:10.1111/ceo.13761.

    PMID: 32279425
  29. 29

    New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy.

    Fabiani C, Sota J, Sainz-de-la-Maza M, et al.

    Mediators of inflammation 2020; (2020()):8294560 doi:10.1155/2020/8294560.

    PMID: 32410867
  30. 30

    Epidemiology and Clinical Characteristics of Episcleritis and Scleritis in Olmsted County, Minnesota.

    Xu TT, Reynolds MM, Hodge DO, Smith WM

    American journal of ophthalmology 2020; (217()):317-324 doi:10.1016/j.ajo.2020.04.043.

    PMID: 32437669
  31. 31

    Cataract Surgery in the Setting of Scleritis.

    Palkar A, Sudharshan S, George AE, et al.

    Ocular immunology and inflammation 2021; (29(7-8)):1540-1543 doi:10.1080/09273948.2020.1754434.

    PMID: 32463347
  32. 32

    Current insights in the pathogenesis of scleritis.

    Vergouwen DPC, Rothova A, Berge JCT, et al.

    Experimental eye research 2020; (197()):108078 doi:10.1016/j.exer.2020.108078.

    PMID: 32504648
  33. 33

    Presumed tuberculous sclerokeratouveitis in immunocompetent South African patients.

    Mathew D, Smit D

    Eye (London, England) 2021; (35(5)):1377-1383 doi:10.1038/s41433-020-1046-2.

    PMID: 32587384
  34. 34

    Case report-immune recovery posterior scleritis in a HIV positive patient.

    Che X, Jiang J, Qian Y, et al.

    BMC ophthalmology 2020; (20(1)):262 doi:10.1186/s12886-020-01529-3.

    PMID: 32615955
  35. 35

    Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive Factors.

    Shah DN, Al-Moujahed A, Newcomb CW, et al.

    American journal of ophthalmology 2020; (218()):279-287 doi:10.1016/j.ajo.2020.06.019.

    PMID: 32621891
  36. 36

    Scleritis: Differentiating infectious from non-infectious entities.

    Murthy SI, Sabhapandit S, Balamurugan S, et al.

    Indian journal of ophthalmology 2020; (68(9)):1818-1828 doi:10.4103/ijo.IJO_2032_20.

    PMID: 32823398
  37. 37

    Clinical profile of patients with anterior nodular scleritis in India.

    Patnaik G, Sudharshan S, George AE, et al.

    Indian journal of ophthalmology 2020; (68(9)):1925-1928 doi:10.4103/ijo.IJO_2154_19.

    PMID: 32823416
  38. 38

    Clinical characteristics and efficacy of methotrexate in Japanese patients with noninfectious scleritis.

    Hiyama T, Harada Y, Kiuchi Y

    Japanese journal of ophthalmology 2021; (65(1)):97-106 doi:10.1007/s10384-020-00778-5.

    PMID: 33107015
  39. 39

    Monocular posterior scleritis presenting as acute conjunctivitis: A case report.

    Li YZ, Qin XH, Lu JM, Wang YP

    World journal of clinical cases 2020; (8(20)):5030-5035 doi:10.12998/wjcc.v8.i20.5030.

    PMID: 33195678
  40. 40

    Current Approach for the Diagnosis and Management of Noninfective Scleritis.

    Dutta Majumder P, Agrawal R, McCluskey P, Biswas J

    Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2020; (10(2)):212-223 doi:10.1097/APO.0000000000000341.

    PMID: 33290287
  41. 41

    Nodular anterior scleritis associated with Berger's disease.

    Constancio EG, Alves DLS, Mello LGM, et al.

    Arquivos brasileiros de oftalmologia 2021; (84(1)):74-77 doi:10.5935/0004-2749.20210011.

    PMID: 33470345
  42. 42

    Scleraxis expressing scleral cells respond to inflammatory stimulation.

    Atta G, Schroedl F, Kaser-Eichberger A, et al.

    Histochemistry and cell biology 2021; (156(2)):123-132 doi:10.1007/s00418-021-01985-y.

    PMID: 33966129
  43. 43

    Scleritis and sclerokeratitis associated with IgA vasculitis: A case series.

    Hernanz I, Larque AB, Quintana LF, et al.

    American journal of ophthalmology case reports 2021; (22()):101100 doi:10.1016/j.ajoc.2021.101100.

    PMID: 33997470
  44. 44

    Rheumatoid Arthritis Associated Episcleritis and Scleritis: An Update on Treatment Perspectives.

    Promelle V, Goeb V, Gueudry J

    Journal of clinical medicine 2021; (10(10)) doi:10.3390/jcm10102118.

    PMID: 34068884
  45. 45

    Infectious Scleritis: Pathophysiology, Diagnosis, and Management.

    Yu J, Syed ZA, Rapuano CJ

    Eye & contact lens 2021; (47(8)):434-441 doi:10.1097/ICL.0000000000000813.

    PMID: 34224444
  46. 46

    Clinical Relevance of Autoantibodies and Inflammatory Parameters in Non-infectious Scleritis.

    Vergouwen DPC, Ten Berge JC, Boukhrissi S, et al.

    Ocular immunology and inflammation 2022; (30(7-8)):1859-1865 doi:10.1080/09273948.2021.1966050.

    PMID: 34464233
  47. 47

    Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.

    Sota J, Girolamo MM, Frediani B, et al.

    Ophthalmology and therapy 2021; (10(4)):777-813 doi:10.1007/s40123-021-00393-8.

    PMID: 34476773
  48. 48

    A novel technique of full-thickness scleral debridement in fulminant necrotising infectious scleritis and its outcomes-a consecutive case series.

    Karkhur S, Soni D, Sharma B

    International ophthalmology 2022; (42(2)):581-592 doi:10.1007/s10792-021-02030-6.

    PMID: 34613564
  49. 49

    Choroidal involvement in non-infectious posterior scleritis.

    Vermeirsch S, Testi I, Pavesio C

    Journal of ophthalmic inflammation and infection 2021; (11(1)):41 doi:10.1186/s12348-021-00269-9.

    PMID: 34705127
  50. 50

    Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review.

    Dammacco R, Guerriero S, Alessio G, Dammacco F

    International ophthalmology 2022; (42(2)):689-711 doi:10.1007/s10792-021-02058-8.

    PMID: 34802085
  51. 51

    Management of noninfectious scleritis.

    Abdel-Aty A, Gupta A, Del Priore L, Kombo N

    Therapeutic advances in ophthalmology 2022; (14()):25158414211070879 doi:10.1177/25158414211070879.

    PMID: 35083421
  52. 52

    Clinical profile, treatment, and visual outcome of scleritis: A single ophthalmologist experience.

    Magesan K, Patnaik G, Majumder PD, Biswas J

    Oman journal of ophthalmology 2022; (15(2)):153-158 doi:10.4103/ojo.ojo_168_21.

    PMID: 35937739
  53. 53

    [Diagnostic and Therapeutic Management of Episcleritis and Scleritis].

    Turgut F, Dingerkus V, Tappeiner C, Becker M

    Klinische Monatsblatter fur Augenheilkunde 2023; (240(5)):725-738 doi:10.1055/a-2022-0689.

    PMID: 36827997
  54. 54

    Systemic Disease Associations in a Cohort of Hispanic Patients with Scleritis.

    Arruza C, Requejo Figueroa GA, Colón J, et al.

    Journal of clinical medicine 2023; (12(5)) doi:10.3390/jcm12051969.

    PMID: 36902755
  55. 55

    Scleral Proteome in Noninfectious Scleritis Unravels Upregulation of Filaggrin-2 and Signs of Neovascularization.

    Vergouwen DPC, Ten Berge JC, Guzel C, et al.

    Investigative ophthalmology & visual science 2023; (64(3)):27 doi:10.1167/iovs.64.3.27.

    PMID: 36930145
  56. 56

    Identifying TNF and IL6 as potential hub genes and targeted drugs associated with scleritis: A bio-informative report.

    Yan F, Liu Y, Zhang T, Shen Y

    Frontiers in immunology 2023; (14()):1098140 doi:10.3389/fimmu.2023.1098140.

    PMID: 37063831
  57. 57

    ANCA-associated scleritis: impact of ANCA on presentation, response to therapy and outcome.

    Perray L, Nguyen Y, Clavel Refregiers G, et al.

    Rheumatology (Oxford, England) 2024; (63(2)):329-337 doi:10.1093/rheumatology/kead252.

    PMID: 37233203
  58. 58

    Necrotizing Scleritis: A Review.

    Dutta Majumder P, Agarwal S, Shah M, et al.

    Ocular immunology and inflammation 2024; (32(7)):1405-1419 doi:10.1080/09273948.2023.2206898.

    PMID: 37279404
  59. 59

    Clinical Features, Treatment, and Visual Outcomes of Posterior Scleritis from Tertiary Eye Care Center.

    Tellioğlu A, Yargı Özkoçak B, Kemer Atik B, et al.

    Ocular immunology and inflammation 2024; (32(7)):1323-1329 doi:10.1080/09273948.2023.2241556.

    PMID: 37549312
  60. 60

    Etanercept-associated episcleritis: a pediatric case report of a paradoxical adverse reaction and review of the literature.

    Küçükali B, Gezgin Yıldırım D, Esmeray Şenol P, et al.

    Clinical rheumatology 2024; (43(2)):799-808 doi:10.1007/s10067-023-06793-4.

    PMID: 37845415
  61. 61

    Potential Biomarkers for Noninfectious Scleritis Identified by Serum and Tear Fluid Proteomics.

    Vergouwen DPC, Kolijn PM, de Hoog J, et al.

    Ophthalmology science 2024; (4(1)):100407 doi:10.1016/j.xops.2023.100407.

    PMID: 38054106
  62. 62

    Scleritis and Development of Immune-Mediated Disease: A Retrospective Chart Review.

    Morrison T, Gottman M, Do T, et al.

    The Journal of rheumatology 2024; (51(8)):825-830 doi:10.3899/jrheum.2023-0788.

    PMID: 38302174
  63. 63

    Morphometric Assessment of Sclera and Ciliary Body in Patients with Noninfectious Anterior Scleritis: A Quantitative Study Using Ultrasound Biomicroscopy.

    Liu T, Ma G, Xu W, et al.

    Ocular immunology and inflammation 2024; (32(9)):2000-2007 doi:10.1080/09273948.2024.2315189.

    PMID: 38376887
  64. 64

    Syphilitic scleritis and episcleritis: A review.

    Shields MK, Furtado JM, Lake SR, Smith JR

    Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2024; (13(3)):100073 doi:10.1016/j.apjo.2024.100073.

    PMID: 38795870
  65. 65

    Autologous Pericranium Graft for Necrotizing Scleritis.

    Copete S, Fagúndez-Vargas MA, López-Martínez F, et al.

    Cornea 2024; (43(12)):1567-1569 doi:10.1097/ICO.0000000000003643.

    PMID: 39079757
  66. 66

    Clinical and Imaging Characteristics of Posterior Scleritis in Children.

    Katzir A, Amer R

    Ocular immunology and inflammation 2025; (33(7)):1235-1242 doi:10.1080/09273948.2025.2455963.

    PMID: 39847430
  67. 67

    The Global Epidemiology of Scleritis: A Systematic Review and Meta-analysis.

    Cifuentes-González C, Mejía-Salgado G, Rojas-Carabali W, et al.

    American journal of ophthalmology 2025; (273()):13-32 doi:10.1016/j.ajo.2025.01.019.

    PMID: 39892801
  68. 68

    Infectious scleritis: a review of etiologies, clinical features, and management strategies.

    Sharma S, Sheth JU, Murthy SI

    Frontiers in ophthalmology 2025; (5()):1493831 doi:10.3389/fopht.2025.1493831.

    PMID: 39990248
  69. 69

    Insights into scleral violaceous hue in anterior scleritis: anterior segment optical coherence tomography evaluation.

    Sutra P, Pothikamjorn T, Lopez S, et al.

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2025; (263(7)):1997-2004 doi:10.1007/s00417-025-06788-8.

    PMID: 40095049
  70. 70

    Isolated ANCA-associated scleritis successfully treated with systemic rituximab; a case report and review of literature.

    Tahavvori M, Fekri S, Hassanpour K, et al.

    BMC ophthalmology 2025; (25(1)):176 doi:10.1186/s12886-025-04027-6.

    PMID: 40197146
  71. 71

    Infectious scleritis: a comprehensive narrative review of epidemiology, clinical characteristics, and management strategies.

    Ghanbari H, Rahimi M, Momeni A, et al.

    Therapeutic advances in ophthalmology 2025; (17()):25158414251357776 doi:10.1177/25158414251357776.

    PMID: 40718796
  72. 72

    Idiopathic Posterior Scleritis Complicated by Optic Perineuritis and Ocular Motility Disorder Successfully Controlled with Adalimumab: A Case Report.

    Numaga Y, Aoyama Y, Tanaka R

    Case reports in ophthalmology 2025; (16(1)):916-925 doi:10.1159/000549539.

    PMID: 41404192
  73. 73

    Scleritis and associated systemic diseases: contribution of systemic examination, follow-up, and additional investigations.

    Soubrier M, Vasseneix C, Jacquot R, et al.

    Journal of ophthalmic inflammation and infection 2025; (16(1)):7 doi:10.1186/s12348-025-00566-7.

    PMID: 41447412
  74. 74

    Sequential ocular surgeries and multimodal immunosuppression for bilateral, medically refractory seronegative scleritis with severe peripheral corneal stromal thinning: a case report.

    Fidan DG, Butler NJ, Kohanim S, et al.

    BMC ophthalmology 2026; (26(1)).

    PMID: 41992188
  75. 75

    Atypical Cogan's Syndrome Presenting as Anterior Scleritis: Case Report.

    Mendes J, Mendes F, Valente Fortunato D, et al.

    Case reports in ophthalmology 2026; (17(1)):371-379 doi:10.1159/000551227.

    PMID: 42039758